The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired ... microangiopathic hemolytic anemia (MAHA) (loss of ...

Expresses differences in erythrocyte size in an individual specimen Used to detect anisocytosis. Increased in immune hemolytic anemia, SS and SC disease, and hereditary spherocytosis ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Jan. 9, 2025 — Researchers find cell migration doesn't only rely on generating force. A professor of mechanical engineering and materials science found that groups ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Healthcare organizations may benefit from switch therapy by allowing the care of patients with community-acquired pneumonia to be standardized and streamlined. Clinical practice guidelines may be ...

Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...

MONDAY, Jan. 6, 2025 (HealthDay News) -- For patients with acute myocardial infarction (MI) and anemia, the primary outcome of 30-day mortality or MI does not differ with a restrictive versus liberal ...

There are more than 10 common skin diseases seen in adults, such as acne, atopic dermatitis (eczema), cold sores, hives, and psoriasis. It can be difficult to identify these skin problems by ...

7 January 2025 Unquestionably, US drugmaker Vertex Pharmaceuticals is the dominant drug developer in the cystic fibrosis (CF) space. How has the company achieved this — on the R&D and patient access ...